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Abstract
Objective—First-degree relatives (FDRs) of people diagnosed with colorectal cancer (CRC) have
a two- to three-fold increased risk of developing the same disease. Tailored print interventions based
on behavior change theories have demonstrated considerable promise in facilitating health-promoting
behaviors. This study compared the impact of two mailed print interventions on CRC screening
outcomes among FDRs.
Methods—This randomized trial compared effects of two mailed print interventions -- one tailored
and one nontailored – on participation in CRC screening among FDRs of CRC survivors. Data
collected via phone interviews from 140 FDRs at baseline, one week post-intervention, and three
months post-intervention.
Results—At three months, both the tailored and nontailored interventions yielded modest but
statistically insignificant increases in adherence to any CRC screening test (14% vs. 21%,
respectively; p=0.30). While there were no main effects for tailored versus nontailored interventions,
there were significant interactions that showed that the tailored print intervention had significantly
greater effects on forward stage movement for CRC screening depending on stage of adoption at
baseline, race, and objective CRC risk. Receipt of the tailored intervention was 2.5 times more likely
to move baseline precontemplators and contemplators forward in stage of adoption for colonoscopy
(95% CI=1.10–5.68) and was three times more likely to move Caucasians forward in stage of
adoption for FOBT (95% CI=1.00–9.07). In addition, the tailored intervention was 7.7 times more
likely to move people at average risk forward in stage of adoption for colonoscopy (95% CI=1.25–
47.75).
Conclusion—The tailored print intervention was more effective at moving Caucasians, those in
precontemplation and contemplation at baseline, and those at average risk forward in their stage of
adoption for CRC screening.
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Practice Implications—Both tailored and nontailored print interventions showed moderate
effects for increasing CRC screening participation. Tailored print interventions may be more effective
for certain subgroups.
1. Introduction
Colorectal cancer (CRC) is the most common cause of cancer deaths in non-smokers in the
United States [1]. An estimated 153,750 people in the U.S. will be diagnosed and more than
52,000 will die from this disease in 2007. Some individuals being at greater risk than others
[2]. Approximately 25% of new CRC cases occur in individuals who have a first-degree relative
(FDR) with the disease [3]. Other than age, having a positive family history is the most common
risk factor [4]. Whereas, without preventive action, a person at average risk has a 6% chance
of developing CRC sometime during his or her lifetime, those with a family history of CRC
have a two- to eight-fold increased risk of developing the disease [4–10].
When discovered early, CRC is highly treatable. The natural development of CRC from polyps
provides the opportunity for cancer prevention through identification and removal of these
cancer precursors [11,12]. Endoscopic removal of precancerous polyps has been found to
decrease CRC incidence by 75% to 90% [3]. Efforts to increase participation in screening
among the general population can result in significant CRC mortality and morbidity reduction.
Increasing screening among people at increased risk, including close relatives of colorectal
cancer survivors, would yield even greater reductions in morbidity and mortality from this
preventable disease.
Recent advances in our knowledge of CRC risk factors, including family history, have resulted
in screening guidelines stratified by risk [13]. Colonoscopy is the only recommended screening
test for individuals at increased risk for CRC, whereas guidelines for people at average risk
include choices among fecal occult blood testing, sigmoidoscopy, barium enema, and
colonoscopy. However, because published guidelines that stratify screening test options by
risk are relatively new and continue to evolve, both patients and health care providers are often
uncertain about which tests are appropriate for whom.
Tailored health communications have demonstrated potential to influence health behavior
change and have been shown to increase smoking cessation, dietary change, and cancer
screening more effectively than nontailored communications that do not take into account the
characteristics of their intended audience [14,15]. Although studies have compared tailored
and nontailored communications to increase breast cancer screening, we know little about the
relative efficacy of tailored versus nontailored interventions to promote CRC screening. Given
the complexity of guidelines which recommend different screening tests depending on an
individual’s risk factors, interventions that deliver tailored messages based on risk assessment
are necessary if the goal is to increase participation in risk-appropriate screening.
Marcus and colleagues conducted one of the few randomized trials to examine the efficacy of
tailored print materials to promote CRC screening among callers to the Cancer Information
Service [16]. These investigators used a 4-group design and enrolled more than 4000 callers
to the Cancer Information Service to test the effects of tailoring, multiple mailouts, and re-
tailoring of print materials. Four types of mailed print interventions were compared: a single
nontailored mailout of print materials (the control condition), a single tailored mailout of print
materials, four tailored mailouts of print materials sent over 12 months, and four mailouts of
print materials that were re-tailored based on new/updated information obtained from
participants at 6 months. Although there was no difference in CRC screening at 14 months
between the single tailored and single groups, compelling evidence for tailoring was found
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when subgroup analyses were conducted. Among younger participants aged 50–59 years, the
single mailout of print materials outperformed the single mailing of nontailored materials.
Noar and colleagues recently conducted a meta-analysis of 57 studies testing tailored print
behavior change interventions. The majority of health behaviors studied included smoking
cessation, dietary change and mammography. Results in dictated that tailored print
interventions showed a small sample size-weighted mean effect size of r=.074 (95% CI=.066–.
082), significantly outperforming nontailored messages [17].
The purpose of this study was to compare the efficacy of a mailed tailored print intervention
with a nontailored print intervention on CRC screening adherence and stage of adoption among
first-degree relatives (FDRs) of CRC survivors. The following research questions were
addressed:
1. Which mailed print intervention (tailored vs. non-tailored) is more efficacious for
promoting CRC screening adherence and forward stage movement in FDRs of CRC
survivors?
2. Which individual characteristics influence intervention efficacy among FDRs of CRC
survivors?
1.1. CRC Screening Guidelines
Current guidelines for CRC screening published by the American Cancer Society (ACS) are
stratified by CRC risk [13]. Individuals are deemed to be at average risk for CRC in the absence
of known risk factors other than age. For average risk persons, screening recommendations
start at age 50 and include five options: 1) annual fecal occult blood or fecal immunochemical
test; 2) flexible sigmoidoscopy every 5 years; 3) sigmoidoscopy every 5 years with annual fecal
occult blood test; 4) colonoscopy every 10 years; or 5) double contrast barium enema every 5
years. Individuals are at increased risk if they have a significant family history of CRC or a
personal history of CRC, adenomas, or inflammatory bowel disease.
Screening recommendations have been stratified based on the number of risk factors present,
including family history. People who have only one FDR who had CRC after the age of 60 are
considered to be at average risk and should be offered the same five screening options as people
with no family history. In contrast, having one FDR with CRC diagnosed before age 60, or
having 2 or more FDRs with CRC places people at increased risk for CRC. Appropriate
screening for these at-risk individuals includes total examination of the colon via colonoscopy
every 10 years starting at age 40 or ten years earlier than the age at diagnosis of the youngest
affected relative, whichever is earlier [13].
1.2. Screening among Relatives of Colorectal Cancer Survivors
Research on screening behaviors of first-degree relatives of individuals with CRC has yielded
conflicting results. In several early studies, although FDRs were more likely to agree to
participate in screening, they were no more likely to complete the test than those without a
family history [18,19]. In a recent cross-sectional survey of siblings of people with colon
cancer, 57% were found to be currently on schedule with some kind of screening, not
necessarily a risk-appropriate test [20]. This rate was only slightly higher than that of the
general population.
Another study indicated that although half (50.5%) of FDRs 50 years or older reported ever
having had an FOBT, only 18.5% had had an FOBT within the past year [21]. Rates of screening
with sigmoidoscopy were actually lower than those of the general population, with 30% of
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FDRs reporting that they had ever had a sigmoidoscopy and 21% having ever had a
colonoscopy.
In a study of 83 unaffected twin sisters of CRC patients, lifetime screening rates were high,
with 88% of twins having ever had an FOBT and 69% having ever had a flexible sigmoidoscopy
[22]. Despite these high lifetime screening rates, however, failure to adhere to recommended
intervals for repeat screening was evident. Twins reported having an FOBT only once every
3–4 years, and only 49% reported having had a sigmoidoscopy in the past 5 years.
A number of studies have indicated that relatives of cancer survivors may be more responsive
to interventions to increase screening participation than persons without a family history. In
one study, siblings of CRC cases (n=133) and control siblings were mailed a letter inviting
their participation in a CRC screening program along with a sample FOBT card [23]. Letters
sent to siblings informed them of their increased risk status. Telephone interviews were
conducted three weeks later to measure outcomes. Although a greater proportion of siblings
of CRC patients (52%) returned completed FOBT cards compared to control siblings (37.7%),
participation rates in both groups were quite low.
Harris and Byles surveyed 225 FDRs of CRC patients to explore knowledge, attitudes, and
screening participation [24]. Although there were high levels of awareness and positive
attitudes toward screening, screening rates were low, with only 3 relatives having being
screened in accordance with current screening guidelines. With screening participation broadly
defined as any FOBT, sigmoidoscopy, or colonoscopy during the past six years, only 57% of
participants had ever been screened.
2. Methods
We used the Health Belief Model and the Transtheoretical Model/Stages of Change theory to
guide intervention development through identifying predictors and mediators of screening
behavior. The HBM proposes that individuals will take action to prevent, screen for, or control
a health condition if they: 1) consider themselves to be susceptible to or at risk for the condition;
2) believe the condition has serious consequences; 3) believe that a particular course of action
will reduce either their susceptibility to or the severity of the condition; and 4) believe that the
anticipated barriers (costs) of taking the action are outweighed by the benefits [25]. Self-
efficacy, originally conceptualized by Bandura [26,27], was added to the HBM to increase its
explanatory power. Self-efficacy is defined as “the conviction that one can successfully execute
a specific behavior required to produce the outcomes” [26].
The TTM describes behavior change as a dynamic process through which individuals move in
a series of discrete phases or “stages of change” [28]. The five stages have been labeled: 1)
Precontemplation, 2) Contemplation, 3) Preparation, 4) Action, and 5) Maintenance. Relapse
can occur during any phase in this process and may or may not be followed by a resumption
of progress through the stages. Precontemplators have no intention of engaging in the relevant
behavior in the foreseeable future; they are either uninformed or underinformed about the
consequences of their behavior, refuse to acknowledge their risk, or have decided for some
other reason not to engage in the behavior. Contemplators have begun to consider engaging in
the behavior of interest. Some people remain in contemplation for a long period of time because,
although they are aware of the benefits (pros) of the behavior, they are also highly aware of
the barriers (cons). The balance between pros and cons can keep people stuck in the
contemplation stage [29]. Preparation is the stage at which people make the decision to engage
in the behavior and is most commonly characterized by having a plan of action for the behavior
change. Actors are those who have actually implemented the behavior and perform it at the
level professionals agree is sufficient to reduce the risk. Maintenance is the stage during which
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the behavior is routine and is characterized by attempts to prevent relapse. The TTM has been
used to guide effective mammography interventions [30,31]. In this study, stages of change
were defined independently for FOBT, sigmoidoscopy, and colonoscopy in this study as shown
in Table 1.
2.1. Research Design
A two-group randomized design was used to determine if a tailored print intervention was more
effective than a nontailored print brochure at increasing CRC screening or advancing stage of
CRC screening among FDRs. The sample for this analysis was drawn from the larger
population of people who were screening eligible, that is those who were either: 1) 50 years
of age and older; or 2) between 40 and 50 years but at increased risk for CRC. Follow-up
telephone interviews were conducted at one week post-intervention (process evaluation) and
at 3 months post-intervention delivery (outcomes).
2.2. Interventions: Tailored and Non-tailored
The tailored print intervention was customized for each participant. An extensive library of
potential messages was developed, and tailoring algorithms were created to select individual
messages from the library. Messages were selected based on baseline telephone interview data
and assembled into an intervention booklet that was unique to each participant. Theoretical
constructs from the HBM and the TTM that guided intervention development included
perceived susceptibility (risk), perceived benefits, perceived barriers, and self-efficacy related
to each screening test. Stage of change for each screening test was also assessed during the
baseline interview. David Farrell, MPH, and colleagues from People Designs, Inc. wrote the
computer software which executed the tailoring algorithms, assisted with tailored message
development, and designed the layout and graphics for the 10-page, 8½ ×11 inch booklets.
Demographic variables and CRC risk factors, including age, family history, and presence of
other comorbid conditions that affect CRC risk (personal history of polyps or inflammatory
bowel disease), were also collected at baseline and integrated into the tailored intervention.
Risk factors were used to determine each participant’s objective CRC risk and to generate a
tailored risk profile and the appropriate screening test recommendation. Assessments of
individual barriers to each screening test were also conducted through the baseline interview.
Messages designed to help participants overcome their top three barriers were included in the
tailored intervention. Variables that were used for tailoring and sample messages are listed in
Table 2.
The nontailored print intervention used for comparative purposes was the American Cancer
Society (ACS) brochure titled Colon Testing Can Save Your Life (2003). This brochure
contained information about CRC, symptoms, risk factors, and current screening guidelines,
with information on screening tests provided in a tabular format along with cost, advantages,
disadvantages, and limitations of each test described. The brochure encourages readers to
discuss CRC screening with their health care provider. Consistent with the tailored print
intervention, participants assigned to this comparison group received the mailed ACS brochure
within one month of baseline data collection. Additional details and samples of the tailored
and nontailored interventions are included in the appendices.
2.3. Recruitment
After obtaining approval from the Institutional Review Boards and from treating physicians,
colorectal cancer survivors were contacted to refer FDRs. Survivors were identified through
cancer registries and by in-person contact in oncology clinics. Letters and study brochures were
sent to all approved/referred survivors to introduce the study. One week after letters were sent,
trained recruiters called survivors who did not decline to be contacted to explain the study and
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determine interest. Survivors who verbally consented to participate were asked to: 1) return
the signed written consent form; 2) provide family history information; and 3) refer their FDRs
who were over age 40 to the study. One hundred forty survivors agreed to participate, returned
consent forms, and provided FDR referrals.
Eligibility criteria for FDRs included being: 1) at least 40 years old; 2) able to read English;
3) without a personal history of colorectal cancer; and 4) non-adherent with American Cancer
Society (ACS) screening guidelines. Non-adherence to ACS guidelines was defined as not
having had either: 1) an FOBT in the past year and a flexible sigmoidoscopy in the past 5 years;
or 2) a colonoscopy in the past 10 years. FDRs were recruited using the same mail and phone
follow-up procedures described above. After FDRs provided verbal consent, baseline
interviews were conducted by trained interviewers. Follow-up phone interviews to assess
outcomes were conducted approximately 3 months after the baseline interview (+ or − one
week). Participants received a $20 gift certificate following completion of the follow-up
interview.
Subject enrollment, attrition and retention rates are summarized in Figure 1. A total of 217
FDRs were enrolled, although nine participants were not able to be reached to complete the
baseline interview. Computerized randomization occurred after the baseline interview was
completed, resulting in 103 subjects in the tailored print intervention group and 105 in the
nontailored group. Ten participants could not be reached at three months and three refused to
complete the follow-up interview.
2.4. Measures and Data Analyses
We assessed screening adherence and movement across stages of adoption for screening as the
primary outcomes of interest in this study. Screening adherence was measured in 5 different
ways: 1) adherence to any test was a dichotomous variable (Yes/No) defined as having had
any of the three screening tests (FOBT, sigmoidoscopy, or colonoscopy) since baseline; 2)
adherence to the risk-appropriate test was a dichotomous variable defined as having had the
screening test appropriate for an individual’s risk since baseline; and 3) adherence to each
test (FOBT, sigmoidoscopy, and colonoscopy) separately.
Movement across stages of adoption was assessed by examining change in stage from baseline
to follow-up. Specifically, at baseline we measured three possible stages (precontemplation,
contemplation, and preparation). At follow-up, there were four possible stages
(precontemplation, contemplation, preparation, and action). Thus, there were six possible
movements in stage (−2 stages, −1 stage, no movement, +1 stage, +2 stages, +3 stages.
Univariate analyses were conducted for all continuous variables to examine their underlying
distribution. To compare intervention groups (tailored vs. non-tailored) on categorical sample
characteristics and outcomes (adherence and stage movement), Pearson chisquare tests were
used. If 20% of expected cell counts were less than 5, two-sided Fisher's exact tests were used.
Intervention effects on adherence and stage movement, adjusting for baseline characteristics,
were assessed with logistic regression models.
Screening adherence was determined for each individual screening method, for adherence to
any test, and adherence to the right test. In bivariate analyses, stage movement was assessed
at the most detailed level (all seven categories), and also at the two-category level described
next. For multivariate analyses, consistent with our previous analyses, stage movement was
categorized into two groups (forward movement vs. no movement or backward movement) to
avoid sparseness in outcome categories.
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3. Results
3.1. Sample Description
Of 208 subjects who enrolled and completed baseline interviews, 177 completed the three
month follow-up interview. However, because the purpose of the present study was to analyze
efficacy of the interventions to promote screening, the 37 people who were younger than 50
and at average risk for CRC were excluded from analyses. This left a total of 140 participants
− 61 (44%) in the tailored intervention group and 79 (56%) in the nontailored group.
As shown in Table 3, participants in both groups were similar on all demographic variables.
Mean age was 54 years for the tailored group and 53 years for the nontailored group, and mean
number of years of education was near 15 (i.e., three years of college) for both groups.
Participants in both groups were predominantly female, Caucasian, employed with a medium-
tohigh income, insured, and married or living with a partner. The majority of participants were
categorized as at increased risk for CRC due to the strength of their family or personal history.
We analyzed data for questions 1 and 2 adjusting for potential covariates including race, age,
marital status, and employment. Point estimates for the odds ratios were unchanged, therefore,
the unadjusted results are reported here.
3.2 Process Evaluation: Readership, Relevance, and Satisfaction with Print Interventions
Readership, relevance and satisfaction with both the tailored and nontailored print interventions
were examined with a subsample of 123 participants using Pearson chi-square tests of general
association (See Table 4). When 20% or more of the cells of the contingency table had expected
counts less than 5, the two-sided Fisher's exact test for the overall cross-classification table
was used. Approximately 88% of participants in both intervention groups had read the materials
completely and approximately 95% had saved the information. Participants in both groups
universally agreed (100%) that the information was easy to understand and visually appealing.
Over 95% of subjects reported the information was interesting and that they would recommend
this information to others. More than 80% of participants who received both print interventions
had or were planning to discuss the information with their doctors. A higher percentage of
subjects who received the tailored print intervention had discussed the information with their
families compared to the nontailored brochure (61 % vs. 49%, respectively), however this
difference was not significant (p=.20).
One significant group difference favoring the tailored intervention was observed on one item
– the information was written especially for me (p=.002). A higher proportion of the tailored
group (92%) agreed or strongly agreed that the information was written especially for them,
compared to 71% in the nontailored group. Participants who received the tailored intervention
perceived the material to be more personally relevant to them. Interestingly, a significantly
higher proportion of the nontailored group (67%) compared to the tailored group (39%)
reported that the materials had changed their opinion about talking with their doctor about CRC
screening (p=.002).
3.3. Research Question 1
Which print intervention (tailored vs. non-tailored) is more efficacious for
promoting CRC screening and forward stage movement among FDRs of CRC
survivors?—As shown in Table 5, there were no significant differences between groups on
overall adherence and stage movement. In terms of absolute percentages, three-month
adherence to any screening test (FOBT, sigmoidoscopy or colonoscopy) was slightly lower
among recipients of the tailored intervention compared to the nontailored intervention; 14%
versus 21%, respectively (p=.30). Rates for adherence to the risk-appropriate test and for each
individual test were similar between groups. Rates for adherence to the specific tests (FOBT
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and colonoscopy) must be interpreted together in that participation in colonoscopy negates the
need for participation in FOBT.
Although adherence rates at three months were modest in both groups, rates for forward stage
movement were slightly higher (See Table 5). Forward stage movement for FOBT was 18%
among tailored intervention recipients versus 12% who received the nontailored brochure (p=.
35). Forward stage movement for colonoscopy was 12% higher in the tailored intervention
group; 36% versus 24% in the nontailored group (p=0.13).
3.4. Research Question 2
Which individual characteristics influence intervention efficacy in FDRs of CRC
survivors?—To examine whether the intervention was more or less effective among
subgroups, we tested interactions between intervention group and participant characteristics
using logistic regression. As shown in Table 6, several significant interactions indicated that
the intervention effect differed by race, objective CRC risk, and baseline stage of adoption for
colonoscopy. The interaction between income and intervention effect was marginally
significant (p=.06).
Among Caucasians, forward stage movement for FOBT was significantly greater in the tailored
group (24%) compared to the nontailored print group (10%). The tailored intervention was
3.01 times more likely to move Caucasians forward in stage of adoption for FOBT than the
nontailored intervention (95% CI=1.00–9.07). For non-Caucasians, the intervention effect was
not significant.
When those in precontemplation and contemplation at baseline were combined, forward stage
movement for colonoscopy was significantly greater in the tailored group compared to the
nontailored group (36% vs 18%, respectively). The tailored intervention was 2.49 times more
likely to move this subgroup forward in stage compared to the nontailored intervention (95%
CI=1.10–5.68).
The tailored intervention was 7.71 times more likely to move people with average risk for CRC
forward in stage of adoption for colonoscopy (95% CI=1.25–47.75). In contrast, tailored and
nontailored interventions were equally effective at moving people with increased CRC risk
forward in stage of adoption for colonoscopy.
Among those at the highest household income level (> $75, 000), forward movement for FOBT
was marginally significantly greater (p=.06) among those in the tailored intervention group
compared to the nontailored group (30% vs. 7%, respectively). The tailored intervention was
5.36 times more likely to move participants with higher incomes forward in stage for FOBT
than the nontailored intervention (95% CI= 0.95–30.2). For those with incomes less than
$75,000, the intervention effect was not significant.
4. Discussion and Conclusion
4.1. Discussion
Although the difference in adherence to any CRC screening test between the tailored and the
nontailored intervention groups was not significant overall, adherence rates increased by 14%
and 21%, respectively, indicating a modest effect size for both interventions. While cost-
effectiveness was not examined in this feasibility trial, the nontailored American Cancer
Society brochure represents a moderately effective, inexpensive “minimal prompt”
intervention to promote CRC screening among FDRs.
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Our results are similar to those of Marcus and colleagues who found no significant differences
in CRC screening rates overall between CIS callers who received a single tailored mailout of
print materials and a single nontailored mailout (Marcus, et. al., 2005). One-time interventions,
such as the ones tested here, may have limited efficacy in moving people to action for CRC
screening. Our results lend support to the applicability of the TTM in the context of CRC
screening. Motivating healthy people, even those at increased risk for CRC, to participate in
screening may require multiple contacts and conversations. Findings from other studies have
shown that multiple mailings of tailored print materials outperformed a single, one-time print
intervention to promote CRC screening (Marcus, et.al., 2005).
Noar and colleagues found significant, but small, effect sizes in favor of tailored interventions
(r=.074, 95% CI=0.66–0.82) in their metanalysis of 57 studies (Noar, Benac & Harris, 2007).
These investigators identified several moderators of the effectiveness of tailored interventions
including the type of health behavior change being promoted, type of comparison condition,
type of print material, number of intervention contacts, length of follow-up, as well as number
and type of theoretical constructs and other variables used for tailoring. Larger effect sizes
were observed for interventions that: 1) focused on screening and preventive behaviors; 2) had
more than one contact; 3) used ipsative feedback; 4) used a control, rather than a comparison,
group; 5) had shorter follow-up; and 6) and tailored on four to five constructs. Significant
interactions observed in this study indicated that the intervention effect differed by race,
objective CRC risk, and baseline stage of adoption for colonoscopy. The interaction between
income and intervention effect was marginally significant.
Numerous studies have documented the receipt of a recommendation for CRC screening from
one’s healthcare provider as the most important predictor of participation. Rimer and
colleagues (1999), who compared several interventions to promote breast and cervical cancer
screening in community health centers, reported those who received a combination of tailored
print materials along with a provider prompt did no better than those who received a provider
prompt alone. The interventions in this study did not include any recommendation from the
participants’ providers. Community-based interventions that do not incorporate a provider
recommendation may have limited effectiveness, especially when outcomes that require a
provider’s referral, such as colonoscopy, are of interest.
In this study, participation in screening would have required contact with a health care provider
to obtain a FOBT or referral for endoscopy. Participants were residing in the community and
may not have seen a health care provider in the 3 month timeframe we used for follow-up.
When asked to report the main reason they had not had a CRC screening test, the most
frequently cited reasons included the lack of insurance coverage (n=37), and lack of physician
recommendation (n=17). We did not mail FOBT cards with the print interventions.
We conducted what Glasgow referred to as a “practical clinical trial” [32] in that we compared
a tailored print intervention with a clinically relevant alternative that we considered a “usual
care” or control condition for this at-risk population. The nontailored American Cancer Society
brochure was readily available, inexpensive, required no baseline assessment or computerized
tailoring algorithms to generate. Increasing FDRs’ awareness of their CRC risk and the
importance of screening should constitute “usual care”. The lack of a true control group in this
study, however, could be viewed as a limitation. It is possible that the modest increases
observed in CRC screening could be the result of secular trends rather than the print
interventions, but such trends should have affected outcomes for both groups equally.
One strength of this study was that we included only participants who were non-adherent for
screening at baseline. Numerous studies on CRC screening have included people who were
up-to-date with screening recommendations, thereby directing interventions at individuals who
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did not need them. These studies may waste scarce resources; they also make it difficult to
determine intervention effectiveness. At the same time, our decision to enroll only those FDRs
who, despite having had a family member recently affected by CRC, were not adherent to
screening recommendations may result in a sample of particularly “hard-to-reach” individuals.
Because 30% of the FDRs we contacted were ineligible for the study due to their adherence to
screening guidelines, there may be some support for this hypothesis.
Several limitations of this study should be noted including the limited power related to the
small sample size. The effect of this limited power is to increase the width of the 95%
confidence intervals (i.e., reduced precision) which impacts the degree of confidence one can
place in the odds ratio point estimates. Nevertheless, the results suggest that tailored print
intervention was efficacious to some degree for particular subgroups in this sample. The fact
that screening outcomes were based on self-report is another potential limitation. However,
evidence suggests that self-reports of CRC screening, especially colonoscopy, are highly
accurate and that medical record documentation of FOBT can be limited (Madlensky,
McLaughlin & Goal, 2003; Baier, et. al., 2000). Any systematic under- or over-reporting of
screening by participants in this study should be comparable between intervention groups.
The absence of significant differences might be explained by the fact that 100% of the tailored
intervention group received colonoscopy-specific messages and little to no information about
FOBT or sigmoidoscopy (as opposed to the nontailored group). The tailored intervention was
designed to deliver messages about the recommended screening tests based on CRC risk
assessment. In order to deliver tailored messages to overcome barriers to a specific test,
messages were also tailored based on participants’ stage of adoption for a particular test.
Because all FDRs in this study who were at average risk were in precontemplation or
contemplation for colonoscopy, they received messages about that test.
In addition, because this was an intervention development and feasibility study, only three
months were allowed for follow-up. This 3-month timeframe was likely inadequate to fully
capture screening participation, especially for colonoscopy, in this community-based sample.
For this reason, we considered forward stage movement to be a valid outcome in addition to
screening behavior.
Although recruitment challenges are confronted in every study, recruitment was particularly
difficult in this study because we began during the implementation of HIPAA. Hypervigilence
about privacy issues among providers grew out of concerns about litigation and liability,
especially among smaller practices with less experience with behavioral studies. Responding
to recruitment challenges is critically important to the success of a study. Therefore, we
searched for alternative approaches, including direct advertising of the study to FDRs via
websites, newspapers, and radio. Though these alternative approaches seemed reasonable at
the time, their impact on study outcomes cannot be discounted. In behavioral studies,
participant motivation upon entry into a study can directly affect behavioral outcomes such as
screening. In light of the fact that some of these participants were motivated to join the study,
the large number of FDRs who remained unscreened at three months was disappointing.
Similarly, Marcus and colleagues reported that despite receipt of well developed tailored print
materials, approximately 75% of their participants remained non-adherent at 6 months.
4.2. Conclusion
Results of this study and others indicate that tailored print interventions may be more effective
with certain subgroups of the population. Nontailored print interventions may be a cost-
effective approach to motivating FDRs of colon cancer survivors to be screened. Examining
moderators of intervention efficacy is important if we are to fully understand the impact of our
interventions. Not every intervention will work for everyone. The diversity of the sample with
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regard to race and income allowed us to examine interactions and results demonstrated
important differences in intervention effect. This tailored print intervention resulted in greater
forward stage movement for Caucasians, those with high income, and those in the early stages
of behavioral adoption at baseline.
Further research is needed to understand how we can most effectively motivate populations
who are at risk and at average risk for developing CRC. A reasonable next step would be to
test a tailored print intervention in the context of a managed care setting where access, cost,
and insurance coverage can be removed as barriers. Embedding provider recommendations
into tailored interventions may also be necessary to increase effects. Finally, multiple contacts
and conversations may be needed, especially since awareness of the need for CRC screening
is still low, even among those at increased risk for this often preventable disease.
4.3. Practice Implications
Interventions to promote screening among individuals who are at increased risk for CRC can
save lives. Studies are needed to examine whether the efficacy of mailed print interventions
could be increased if accompanied by a recommendation from the individual’s primary care
provider or delivered in conjunction with a scheduled visit. Identifying those with a family
history of CRC is often a challenge, so being proactive when a relative is diagnosed with CRC
may increase intervention efficacy. Patients who have CRC are often ambassadors for
screening who are eager for their relatives to avoid this disease, so family-based interventions
during active treatment may hold promise as another approach to decreasing the CRC burden
in families at risk.
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Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
Participant Enrollment, Attrition and Retention
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Table 1
Stage definitions by screening test
Precontemplation Contemplation Preparation Action
Fecal Occult
Blood Test
Never had OR had one more than
12 months ago AND does not
intend to have one in next 6
months.
Never had OR had one more
than 12 months ago AND
intends to have one in next 6
months.
Never had OR had one
more than 12 months ago
and has an FOBT kit.
Had one
since
baseline.
Sigmoidoscopy Never had OR had one more than
5 years ago AND does not intend
to have one in next 6 months.
Never had OR had one more
than 5 years ago AND intends
to have one in next 6 months.
Never had OR had one
more than 5 years ago
and has an appointment
to have one.
Had one
since
baseline.
Colonoscopy Never had OR had one more than
10 years ago AND does not intend
to have one in next 6 months.
Never had OR had one more
than 10 years ago AND
intends to have one in next 6
months.
Never had OR had one
more than 10 years ago
and has an appointment
to have one.
Had one
since
baseline.
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Table 2
Tailoring Variables and Sample Tailored Messages
Tailoring Variables Sample Tailored Messages
Stage of Change You may not have thought much about having your colon examined. As a close relative of someone who has been touched
by colon or rectal cancer, screening is especially important for you. This booklet will tell you how colon cancer develops.
Then, we will give you some information about your personal risk for getting this disease. Finally, we will review some
things that might concern you about colon testing, so you can get ready.
Perceived Risk Many people are not aware of the risk factors that increase their chances of getting colon cancer. The major factors that
increase a person’s risk are:
1) Being over 40 years old (if you have a relative who had colon cancer)
2) Having had colon cancer or colon polyps in the past
3) Having an inflammatory bowel disease such as ulcerative colitis (ko-ly-tis) or Crohn’s (kronz) disease
4) Having one or more relatives who had colon cancer.
Objective Risk Factors First, let’s review the factors that increase your personal chance of getting colon cancer. Then we’ll talk about what you
can do to lower your chance of getting it. In addition to getting older, you’ve had 1 close relative who had cancer of the
colon or rectum before they were 60 years old. This means your chances of getting colon or rectal cancer are higher than
those of most people your age.
Your Risk Factors
• Being ____ (exact age)
• Having a family member who had colon or rectal cancer at a young age
What Can You Do To Lower Your Risk?
Begin screening now, if you haven’t already. The American Cancer Society suggests having your entire colon checked
by colonoscopy every 5 years, starting at age 40, or when you are ten years younger than your relative’s age when the
cancer was found, whichever comes first. Talk with your doctor about getting screened soon.
Perceived Barriers to
CRC Screening
Even though having a colonoscopy is very important, it’s natural to have concerns about having one. Don’t let those
concerns keep you from taking this life-saving step. You told us you were most concerned about…(top three endorsed
barriers are addressed).
Having a colonoscopy is painful.
People are often concerned about feeling pain or discomfort during a colonoscopy. Because you are given medicine to
help you relax, it’s likely you’ll sleep through the test and feel no pain at all. If you do feel any pain, tell the doctor and
you can be given more medication. Be sure to talk with the nurse or doctor about your concern before the test.
Your doctor never told you to have a colonoscopy. Sometimes doctors get so busy taking care of patients when they’re
sick, that they don’t take enough time to talk about things you can do to stay healthy…like having a colonoscopy. That’s
why we developed this booklet for you, to help you discuss these colon tests with your doctor the next time you see him
or her. You and your doctor will be glad you did!
Perceived Self-efficacy The best way for you to have your colon examined is with a COLONOSCOPY. A colonoscopy (koh-lun-os-kup-ee) is
a colon screening test that allows a doctor to look inside the entire length of your colon. During a colonoscopy, the doctor
inserts a long, flexible tube with a light into your rectum to examine your entire colon for any unusual growths. Right
before the test, they give you some medicine to help you relax. Most people fall asleep during the test. The test takes
between 30 minutes and an hour, depending on whether there are any growths or polyps that need to be removed.
Afterward, you wait for the relaxing medicine to wear off, and someone needs to drive you home. You will not be able
to drive or work for the rest of that day because it takes several hours for the medicine to wear off. (Graphic included)
One very important part of having a colonoscopy is preparing for the test the day before. Your colon needs to be
completely empty so the doctor can see the inside clearly. To clean out your colon, you will need to do three things on
the day before your colonoscopy:
1) stop eating solid foods (graphic)
2) stop taking certain medicines, (graphic)
3) drink a special laxative to clean out your colon (Fleet Phosphosoda graphic)
As you can imagine, you will spend some time in the bathroom. But this is a very important step in having a colonoscopy.
You can do it! Talk with your doctor now about having a colonoscopy.
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